These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37505107)

  • 21. MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
    Cattell RF; Kang JJ; Ren T; Huang PB; Muttreja A; Dacosta S; Li H; Baer L; Clouston S; Palermo R; Fisher P; Bernstein C; Cohen JA; Duong TQ
    Clin Breast Cancer; 2020 Feb; 20(1):68-79.e1. PubMed ID: 31327729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.
    Lo WC; Li W; Jones EF; Newitt DC; Kornak J; Wilmes LJ; Esserman LJ; Hylton NM
    PLoS One; 2016; 11(2):e0142047. PubMed ID: 26886725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
    Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
    Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
    Hwang KP; Elshafeey NA; Kotrotsou A; Chen H; Son JB; Boge M; Mohamed RM; Abdelhafez AH; Adrada BE; Panthi B; Sun J; Musall BC; Zhang S; Candelaria RP; White JB; Ravenberg EE; Tripathy D; Yam C; Litton JK; Huo L; Thompson AM; Wei P; Yang WT; Pagel MD; Ma J; Rauch GM
    Radiol Imaging Cancer; 2023 Jul; 5(4):e230009. PubMed ID: 37505106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Shi Z; Huang X; Cheng Z; Xu Z; Lin H; Liu C; Chen X; Liu C; Liang C; Lu C; Cui Y; Han C; Qu J; Shen J; Liu Z
    Radiology; 2023 Jul; 308(1):e222830. PubMed ID: 37432083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy.
    Jafri NF; Newitt DC; Kornak J; Esserman LJ; Joe BN; Hylton NM
    J Magn Reson Imaging; 2014 Aug; 40(2):476-82. PubMed ID: 24347097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
    Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
    Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
    Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Dynamic Contrast-enhanced and Diffusion-weighted MRI.
    Zhao R; Lu H; Li YB; Shao ZZ; Ma WJ; Liu PF
    Acad Radiol; 2022 Jan; 29 Suppl 1():S155-S163. PubMed ID: 33593702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.
    van Egdom LSE; Lagendijk M; Heijkoop EHM; Koning AHJ; van Deurzen CHM; Jager A; van Lankeren W; Koppert LB
    Eur J Radiol; 2018 Jul; 104():94-100. PubMed ID: 29857873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL.
    Li W; Arasu V; Newitt DC; Jones EF; Wilmes L; Gibbs J; Kornak J; Joe BN; Esserman LJ; Hylton NM;
    Tomography; 2016 Dec; 2(4):378-387. PubMed ID: 28066808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
    Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
    Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
    Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
    J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
    Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
    Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer.
    Yoen H; Kim SY; Lee DW; Lee HB; Cho N
    Korean J Radiol; 2023 Jul; 24(7):626-639. PubMed ID: 37404105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Kwon BR; Shin SU; Kim SY; Choi Y; Cho N; Kim SM; Yi A; Yun B; Jang M; Ha SM; Lee SH; Chang JM; Moon WK
    Radiology; 2022 Aug; 304(2):310-319. PubMed ID: 35536129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
    Lee HB; Han W; Kim SY; Cho N; Kim KE; Park JH; Ju YW; Lee ES; Lim SJ; Kim JH; Ryu HS; Lee DW; Kim M; Kim TY; Lee KH; Shin SU; Lee SH; Chang JM; Moon HG; Im SA; Moon WK; Park IA; Noh DY
    Breast Cancer Res Treat; 2020 Jul; 182(1):97-105. PubMed ID: 32418044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Pretreatment Multiparametric MRI to Predict Tumor Regression Pattern to Neoadjuvant Chemotherapy in Breast Cancer.
    Liu C; Huang X; Chen X; Shi Z; Liu C; Liang Y; Huang X; Chen M; Chen X; Liang C; Liu Z
    Acad Radiol; 2023 Sep; 30 Suppl 2():S62-S70. PubMed ID: 37019697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.